Product Information
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Saptalis Pharmaceuticals LLC, priced at $0.0728 per ML under NDC 71656002216. Its NADAC has been published 97 times since Nov 27, 2024.
FDA first approved this application on May 21, 2021. Its Orange Book therapeutic-equivalence code is AA.
Strength
3 g/15mL
Manufacturer
Saptalis Pharmaceuticals LLCNDC
71656002216
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211648FDA Approved
5/21/2021
TE Code
AA
On Market Since
10/5/2023
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has been published 97 times since Nov 27, 2024, and over the history we have for it it has risen 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0728 per ML |
|---|---|
| All-time high | $0.0778 (Sep 16, 2026) |
| All-time low | $0.0440 (Dec 17, 2025) |
| 52-week high | $0.0778 |
| 52-week low | $0.0440 |
| Median price | $0.0546 |
| Average price | $0.0555 |
| Largest weekly change | +25.6% (Jun 17, 2026) |
| Weeks tracked | 97 |
| Tracking since | Nov 27, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the POTASSIUM CHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Saptalis Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
POTASSIUM CHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, manufactured by Saptalis Pharmaceuticals LLC, is $0.0728 per ML (NDC 71656002216), effective Sep 30, 2026.
How has the price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID changed over time?
Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has risen 33.3%. It has been tracked across 97 weekly CMS publications since Nov 27, 2024.
What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
Since Nov 27, 2024, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0440 (Dec 17, 2025) to a high of $0.0778 (Sep 16, 2026), with a median of $0.0546 per ML.
Are there cheaper alternatives to POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?
POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID (NDC 71656002216) is labeled by Saptalis Pharmaceuticals LLC, and CMS classifies it as a generic product.